Biotech
News
Outpost Bio receives $3.5M pre-seed
The deep-tech company Outpost Bio secures 3.5 million US dollars in pre-seed funding to systematically model the interaction between humans and the microbiome for the first time.
02.03.2026
02.03.2026
News
Exciva receives 51 million euros Series B for Alzheimer's therapy
Gimv and EQT Life Sciences lead financing round. Capital enables international Phase II study on Alzheimer's agitation.
20.01.2026
20.01.2026
News
DISCO Pharmaceuticals signs license deal with Amgen
Biotech deal. Surfaceome technology convinces pharmaceutical giant. DISCO licenses novel cancer target to Amgen.
07.01.2026
07.01.2026
News
5 million euros seed for Amplifold
DNA origami for rapid tests. Amplifold increases the sensitivity of LFAs by up to 100-fold. The seed financing has now been completed.
10.12.2025
10.12.2025
News
That's fat - € 7.3 million Series A for Melt&Marble
EIC Fund, Beiersdorf and Valio invest. Melt&Marble starts the commercialization of its fermentation-based high-performance fats with € 7.3 million Series A.
08.12.2025
08.12.2025
News
Qorium secures 22 million euros to bring cultivated leather to the mass market
Investors focus on sustainable materials. The biotech from Maastricht wants to revolutionize the leather industry.
11.11.2025
11.11.2025
News
Tubulis closes Series C round for 344 million euros
Munich-based biotech Tubulis accelerates ADC development following strong clinical data. € Total Series C financing increases to € 344 million.
04.11.2025
04.11.2025
News
4.7 million euros pre-series A for smartbax
Medical innovation made in Oberschleissheim. smartbax aims to get to the root of the global resistance problem with novel mechanisms of action.
22.10.2025
22.10.2025
News
Series-C over 308 million euros for Tubulis
Europe in the biotech spotlight. With the largest Series C round of a European biotech company to date, Tubulis is driving clinical trials for TUB-040 and strengthening the European biotech landscape.
15.10.2025
15.10.2025
News
Mevaldi secures financing
Mevaldi scales bio-based building block for polymers and receives funding from HTGF & ICIG Ventures.
10.09.2025
10.09.2025
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?